Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- ASML shares fall as much as 4.9% as European semiconductor stocks decline across the board. AI trades that were popular in the first half lose ground amid concerns over the sustainability of AI spending following the breakthrough of a Chinese open-source model.
- Burberry’s sales growth disappointed investors looking for more proof that the British fashion brand can maintain the pace of its turnaround. Shares fell as much as 7.3% after the UK luxury brand posted first-quarter results that were weaker than expected in Europe and Asia.
- Monte Paschi expressed a number of concerns over a takeover bid by Intesa while highlighting perceived benefits in a broad, rival pitch presented by Banco BPM. Monte Paschi shares slipped as much as 2.2%.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- ASML shares fall as much as 4.3% as the European chip sector becomes swept up in the broader tech selloff across Asian markets and concerns grow over the sustainability of the AI-driven rally in the sector.
- Burberry shares fall as much as 4.4% after the UK luxury brand posted first-quarter results that were weaker than expected in Europe and Asia. Still, analysts say the results are a sign that the company’s turnaround strategy is working.
- Volvo Car plunge as much as 11%, the most since early February, as the automaker misses analyst expectations in the second quarter and lowers its full-year free cash flow guidance.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Broad losses in Asia’s chip sector as shares of TSMC fell 7.3% in Taipei after the world’s largest contract chipmaker raised its spending and revenue projections for the year.
- Kioxia shares declined as much as 14.3%, bringing the market value of the memory chipmaker to more than halve its level at its June peak in intraday trading, as investors remain jittery over the AI trade.
- Seven & I shares increased the most in about six months as the company confirmed they are in discussion regarding investment in Poland's largest convenience store chain, though no decision has been made at this time.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market, a look at the notable movers:
On this episode of Stock Movers:

- Netflix (NFLX) shares decline as much as 6.5% in post-market trading after the streaming service forecast earnings per share for the third quarter and guidance that missed the average analyst estimate.

- Eli Lilly (LLY) agreed to buy AtaiBeckley (ATAI) for as much as $3.8 billion, underscoring growing interest from large drugmakers in psychedelic medicine. Lilly will pay $6.75 a share in cash plus as much as another $2.50 a share if drug-development milestones are met, according to a statement Thursday.

-Abbott (ABT) shares surge as much as 14%, the most intraday since July 2002, after the healthcare company boosted its adjusted earnings per share forecast for the full year, with the updated outlook coming in ahead of the average estimate from analysts. It also posted adjusted profit and net sales for the second quarter that topped expectations. Analysts view the overall results as better than anticipated.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- JB Hunt (JBHT) shares gain after the trucking company reported adjusted earnings per share for the second quarter that beat the average analyst estimate. Analysts highlight progress in the firm’s intermodal business, where the company uses two or more modes of transportation.
- GH Research (GHRS) rises as analysts call it a beneficiary of interest in psychedelics after the Lilly-AtaiBeckley deal. Eli Lilly & Co. agreed to buy AtaiBeckley Inc. for as much as $3.8 billion, underscoring growing interest from large drugmakers in psychedelic medicine.
- Abbott Laboratories (ABT) shares surge. Abbott raised its 2026 profit guidance after a stronger-than-expected second quarter driven by improved performance across most of its business lines. The company now expects adjusted earnings to fall between $5.45 to $5.60 a share this year, and shares rose 14% after the announcement.
See omnystudio.com/listener for privacy information.